Report
Alexander Makar ...
  • Guy Sips
  • Lenny Van Steenhuyse
  • Sandra Cauwenberghs
  • Wim Hoste

KBC Securities Morning Note 12-11-2018 CYAD BB, EVS BB, INTO BB, NYR BB

Celyad: Updates at SITC on mCRC show combo promise
EVS: 3Q18 preview
IO&W: FY18 targets reached: Expansion and a new lease
Nyrstar: Update on lead emission issue in Port Pirie
Underlyings
Celyad Oncology

Celyad is engaged in engineered cell therapy treatments with clinical programs initially targeting indications in cardiovascular disease and oncology. Co. provides C-CATHez, an injection catheter that delivers bio therapeutic agents into the myocardium. Co.'s main product is C-Cure, which is in Phase III clinical trials for the treatment of chronic heart failure secondary to ischemic cardiomyopathy. Co.'s drug product candidates are autologous cell therapy treatments. In autologous procedures, a patient's cells are harvested, selected, reprogrammed and expanded, and then infused back into the same patient.

EVS Broadcast Equipment SA

EVS Broadcasting Equipment is engaged in the development and marketing of audiovisual equipment relating to the processing of pictures and sound. Co. provides solutions based on tapeless workflows with a consistent modular architecture. Co.'s activities are divided into the following regions: Asia-Pacific, Europe, Middle East and Africa, and America.

Intervest Offices & Warehouses SA

Intervest Offices & Warehouses is a Belgian property investment fund. Co. specializes in investments in office buildings and semi-industrial properties situated on locations outside municipal centres. Co.'s business properties are located on the Antwerp-Brussels axis. Its activities can be divided into two business segments: Offices segment which includes the properties that are let to companies for professional purposes as office space; and Semi-industrial buildings segment which includes those premises with a logistical function, storage facilities and high-tech buildings. At Dec 31 2010, Co.'s portfolio consists of 69% in offices buildings and 31% in semi-industrial buildings.

Nyrstar NV

Nyrstar is a multi-metals company, produces and sells zinc and lead, as well as other metals, such as silver, gold, and copper. Co. produces zinc, which is used to protect steel from corrosion to construction and transport sectors. Co.'s products include zinc die casting alloys for hot chamber die casting processes, as well as niche alloys for special purposes to produce everyday objects, such as kitchen and bathroom fittings, toys, lock ware, zippers, and various auto and electronic components; zinc and special zinc alloys for the hot dip galvanizing industry; and zinc-continuous galvanizing products used in the construction, automotive, and consumer goods sectors.

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Alexander Makar

Guy Sips

Lenny Van Steenhuyse

Sandra Cauwenberghs

Wim Hoste

Other Reports on these Companies
Other Reports from KBC Securities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch